BlackRock’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,949,917
Closed -$748M 5896
2022
Q3
$748M Sell
4,949,917
-122,158
-2% -$18.5M 0.03% 598
2022
Q2
$739M Buy
5,072,075
+415,209
+9% +$60.5M 0.02% 625
2022
Q1
$552M Buy
4,656,866
+21,586
+0.5% +$2.56M 0.01% 895
2021
Q4
$639M Buy
4,635,280
+28,207
+0.6% +$3.89M 0.02% 848
2021
Q3
$640M Sell
4,607,073
-84,505
-2% -$11.7M 0.02% 808
2021
Q2
$455M Buy
4,691,578
+908,024
+24% +$88.2M 0.01% 1084
2021
Q1
$259M Buy
3,783,554
+258,603
+7% +$17.7M 0.01% 1527
2020
Q4
$302M Buy
3,524,951
+76,411
+2% +$6.55M 0.01% 1297
2020
Q3
$224M Sell
3,448,540
-82,786
-2% -$5.38M 0.01% 1290
2020
Q2
$258M Buy
3,531,326
+260,157
+8% +$19M 0.01% 1164
2020
Q1
$111M Buy
3,271,169
+352,828
+12% +$12M 0.01% 1565
2019
Q4
$159M Buy
2,918,341
+16,218
+0.6% +$883K 0.01% 1659
2019
Q3
$121M Buy
2,902,123
+411,603
+17% +$17.2M 0.01% 1772
2019
Q2
$109M Sell
2,490,520
-368,373
-13% -$16.1M ﹤0.01% 1837
2019
Q1
$147M Buy
2,858,893
+465,745
+19% +$24M 0.01% 1630
2018
Q4
$88.5M Buy
2,393,148
+225,386
+10% +$8.33M ﹤0.01% 1884
2018
Q3
$81.4M Buy
2,167,762
+77,374
+4% +$2.91M ﹤0.01% 2090
2018
Q2
$82.6M Buy
2,090,388
+201,780
+11% +$7.97M ﹤0.01% 2055
2018
Q1
$48.7M Buy
1,888,608
+734,401
+64% +$18.9M ﹤0.01% 2275
2017
Q4
$31.1M Buy
1,154,207
+12,505
+1% +$337K ﹤0.01% 2524
2017
Q3
$42.7M Buy
1,141,702
+120,770
+12% +$4.51M ﹤0.01% 2356
2017
Q2
$25.5M Buy
+1,020,932
New +$25.5M ﹤0.01% 2637